罗哌卡因硬膜外腔阻滞对老年患者心肌毒性的研究

    Myocardial toxicity of ropivacaine in elderly patients during epidural anesthesia

    • 摘要: 目的: 探讨罗哌卡因硬膜外腔阻滞时对老龄患者心肌的毒性。方法: 60例ASA Ⅱ~Ⅲ级拟硬膜外阻滞下择期手术的老龄患者,随机分成试验组和对照组(各30例)。试验组和对照组硬膜外腔阻滞分别使用罗哌卡因和利多卡因。分别于麻醉前、术毕和术后24 h检测AST、CK、CK-MB和LDH。结果: 试验组术毕和手术后24 h心肌酶谱值分别与麻醉前相比均升高(P<0.05)。对照组分别在同一时间点的心肌酶谱值亦较麻醉前升高(P<0.05)。试验组和对照组间相应时间点心肌酶谱值变化无明显差异。结论: 与临床常用药物利多卡因相比,罗哌卡因硬膜外腔阻滞并不增加对老龄患者心肌的毒性。

       

      Abstract: AIM: To investigate myocardial toxicity of ropivacaine in elderly patients during epidural anesthesia. METHODS: Sixty elderly patients undergoing selective surgery were randomly divided into experimental group (ropivacaine) and control group (lidocaine). Blood samples were obtained from the 60 patients at different intervals to determine their AST, CK, CKMB and LDH. RESULTS: Significant differences were observed between groups in the values of myocardial enzymes before anesthesia and at the end of the surgery or 24 h after surgery (P<0.05), whereas the values of myocardial enzymes of the group of elderly patients were not significantly different between groups at the end of the surgery and 24 h after surgery. CONCLUSION: Compared with lidocaine, administration of ropivacaine has no greater myocardial toxicity during epidural anesthesia. The changes in myocardial enzymes of elderly patients may be mainly related to the surgery process.

       

    /

    返回文章
    返回